RTX Corp·4

Feb 23, 5:09 PM ET

Calio Christopher T. 4

4 · RTX Corp · Filed Feb 23, 2026

Research Summary

AI-generated summary of this filing

Updated

RTX CEO Christopher Calio Exercises SARs and Sells Shares

What Happened
Christopher T. Calio, Chairman, President and CEO of RTX Corp, exercised Stock Appreciation Rights (SARs) for 31,199 shares on Feb 19, 2026 (exercise price reported as $76.00 per share, aggregate $2,371,124) and executed multiple share dispositions the same day. He sold a total of 75,172 shares in several transactions (open-market and a disposition to the issuer) generating approximately $15,326,227 in gross proceeds. One portion of the SAR settlement was treated as a simultaneous sale back to the issuer.

Key Details

  • Transaction date: 2026-02-19; Form 4 filed 2026-02-23 (filed within the SEC’s two-business-day window).
  • Acquired (via SAR exercise): 31,199 shares at $76.00 — $2,371,124 total.
  • Dispositions same day (total sold = 75,172 shares; total proceeds ≈ $15,326,227):
    • 1,041 shares @ $205.25 = $213,670 (open market) — weighted prices ranged $204.11–$205.09 for some lots.
    • 11,420 shares @ $204.70 = $2,337,716 (open market).
    • 11,604 shares @ $204.33 = $2,371,045 (disposition to the issuer).
    • 51,107 shares @ $203.57 = $10,403,796 (open market) — weighted prices ranged $203.09–$204.08 for some lots.
  • Footnote summary: SARs were settled in shares and, for Section 16 reporting, treated as an acquisition at the SAR exercise price with a simultaneous sale back to the issuer of shares having a value equal to SARs × exercise price (see F1). Reported sale prices are weighted averages across multiple same‑day trades (F2, F3).
  • Shares owned after transaction: not specified in the filing.

Context

  • This was an exercise of SARs followed by immediate sales (a form of cashless/settlement transaction): the filing treats the SAR exercise as an acquisition and the corresponding share transfers/sales separately.
  • Sales by executives are common for liquidity, tax or compensation-settlement reasons; the filing is factual and does not indicate motive.

Insider Transaction Report

Form 4
Period: 2026-02-19
Calio Christopher T.
DirectorChairman, President and CEO
Transactions
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-02-19$76.00/sh+31,199$2,371,124165,440.18 total
  • Sale

    Common Stock

    2026-02-19$205.25/sh1,041$213,670164,399.18 total
  • Sale

    Common Stock

    [F2]
    2026-02-19$204.70/sh11,420$2,337,716152,979.18 total
  • Disposition to Issuer

    Common Stock

    2026-02-19$204.33/sh11,604$2,371,045141,375.18 total
  • Sale

    Common Stock

    [F3]
    2026-02-19$203.57/sh51,107$10,403,79690,268.18 total
  • Exercise/Conversion

    Stock Appreciation Right

    2026-02-1931,1990 total
    Exercise: $76.00From: 2021-01-02Exp: 2028-01-01Common Stock (31,199 underlying)
Holdings
  • Common Stock

    (indirect: By Trust)
    4,427
Footnotes (3)
  • [F1]The Stock Appreciation Rights (SARs) were settled in shares in accordance with the terms of the award. For Section 16 reporting purposes, the exercise of SARs for stock is treated as an exempt acquisition of the shares underlying the SARs at the exercise price per share specified in the award of SARs and a simultaneous sale back to the issuer of a number of the underlying shares having a value, based on the market price of the issuer's stock on the date of the exercise, equal to the product of the number of underlying SARs times the exercise price per share.
  • [F2]The reported price is based on a weighted average of multiple same-day transactions with prices ranging from $204.11 to $205.09 per share. Full information regarding the number of shares sold at each separate price is available to the Securities and Exchange Commission, the Issuer or any security holder of the Issuer upon request.
  • [F3]The reported price is based on a weighted average of multiple same-day transactions with prices ranging from $203.09 to $204.08 per share. Full information regarding the number of shares sold at each separate price is available to the Securities and Exchange Commission, the Issuer or any security holder of the Issuer upon request.
Signature
/s/ Jennifer Yahl, as Attorney-in-fact|2026-02-23

Documents

1 file
  • 4
    doc4.xmlPrimary